Pharmaceuticals
A Passover tribute: Kindness from a Jerusalem neighborhood pharmacy
Every year as Seder approaches, we all look for inspiration in how to make our Seder even richer than the year before.
New immigrant pharmacists face discrimination, lack of gov't support despite professional shortage
EcoSupp listens, learns, and delivers
Israeli health officials call for sanctions on anti-vaxxers as flu morbidity rate rises
Australian firm to purchase and export synthetic cannabinoid from Israel
Cannatrek will trial Nextage's synthetic CBN, and providing it meets demand, the two will enter a more permanent agreement in the future.
Israel makes history, launches DIDO III satellite into space
The satellite is carrying a tiny laboratory in which four medical scientific experiments to test drug resistance will be conducted under conditions of micro-gravity.
Pharmaceutical residuals found polluting marine life on Israel's coasts
Unlike other pollutants, pharmaceuticals, which are not fully metabolized in the body, are designed to affect biological systems in even very small amounts.
Health Ministry hides results from satisfactory service survey
The Health Ministry regularly distributes results following surveys regarding its external partners.
In light of coronavirus crisis, resilience is crucial, says Takeda GM
Arie Kramer spoke to 'The Jerusalem Post' about the role of Big Pharma in a health crisis, the importance of meriting people’s trust and what they are doing to help.
Hillel's Tech Corner: CytoReason: Where AI meets drug development
CytoReason’s technology uses a machine learning model to build a molecular level understanding of tissues in diseases on the cellular level.
Moderna, Pfizer start pivotal COVID-19 vaccine trials, eye year-end launch
The study is expected to include about 120 sites globally and could include up to 30,000 participants. It will include regions heavily impacted by COVID-19.
Pfizer, BioNTech say vaccine expected to be ready for approval by December
If it receives marketing approval, the companies are preparing to make up to 100 million doses by the end of 2020 and another 1.2 billion doses by the end of 2021.
BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial
"These first trial results show that the vaccine yields immune activity and causes a strong immune response," said BioNTech's co-founder and Chief Executive Officer Ugur Sahin.
Canadian company Medicago develops plant-based coronavirus vaccine
The company has developed a unique method of creating a vaccine by letting plants do the work. "We're using plants as mini factories," said Natalie Charland, a senior director at Medicago.
